| Appropriateness of cardiovascular disease prevention recommendations obtained from a popular online chat-based artificial intelligence model A Sarraju, D Bruemmer, E Van Iterson, L Cho, F Rodriguez, L Laffin Jama 329 (10), 842-844, 2023 | 222 | 2023 |
| Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance G Murtagh, LJ Laffin, JF Beshai, F Maffessanti, CA Bonham, AV Patel, ... Circulation: Cardiovascular Imaging 9 (1), e003738, 2016 | 166 | 2016 |
| Rise in blood pressure observed among US adults during the COVID-19 pandemic LJ Laffin, HW Kaufman, Z Chen, JK Niles, AR Arellano, LA Bare, ... Circulation 145 (3), 235-237, 2022 | 117 | 2022 |
| Amylose resistant starch (HAM‐RS2) supplementation increases the proportion of Faecalibacterium bacteria in end‐stage renal disease patients: Microbial … MR Laffin, H Tayebi Khosroshahi, H Park, LJ Laffin, K Madsen, HS Kafil, ... Hemodialysis International 23 (3), 343-347, 2019 | 84 | 2019 |
| Hypertension: A companion to braunwald's heart disease GL Bakris, M Sorrentino Elsevier Health Sciences, 2017 | 76 | 2017 |
| Overcoming toxicity and side-effects of lipid-lowering therapies MJ Wilkinson, LJ Laffin, MH Davidson Best Practice & Research Clinical Endocrinology & Metabolism 28 (3), 439-452, 2014 | 67 | 2014 |
| Reproducibility and experience dependence of echocardiographic indices of left ventricular function: side‐by‐side comparison of global longitudinal strain and ejection fraction D Medvedofsky, K Kebed, L Laffin, J Stone, K Addetia, RM Lang, ... Echocardiography 34 (3), 365-370, 2017 | 64 | 2017 |
| Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction G Murtagh, LJ Laffin, KV Patel, AV Patel, CA Bonham, Z Yu, K Addetia, ... Echocardiography 33 (9), 1344-1352, 2016 | 63 | 2016 |
| Renal denervation for the treatment of resistant hypertension: review and clinical perspective R Iliescu, TE Lohmeier, I Tudorancea, L Laffin, GL Bakris American Journal of Physiology-Renal Physiology 309 (7), F583-F594, 2015 | 62 | 2015 |
| Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial M Azizi, M Saxena, Y Wang, JS Jenkins, C Devireddy, F Rader, ... Jama 329 (8), 651-661, 2023 | 48 | 2023 |
| Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients SE Nissen, V Menon, SJ Nicholls, D Brennan, L Laffin, P Ridker, KK Ray, ... Jama 330 (2), 131-140, 2023 | 45 | 2023 |
| Right heart involvement in patients with sarcoidosis MB Patel, V Mor‐Avi, G Murtagh, CA Bonham, LJ Laffin, DK Hogarth, ... Echocardiography 33 (5), 734-741, 2016 | 45 | 2016 |
| Structure of the Hydrated Platinum(II) Ion and the cis-Diammineplatinum(II) Complex in Acidic Aqueous Solution: An EXAFS Study F Jalilehvand, LJ Laffin Inorganic chemistry 47 (8), 3248-3254, 2008 | 42 | 2008 |
| Hypertension and stroke: Pathophysiology and management V Aiyagari, PB Gorelick Humana Press, 2016 | 41 | 2016 |
| Discordance between clinical assessment and invasive hemodynamics in patients with advanced heart failure N Narang, B Chung, A Nguyen, RJ Kalathiya, LJ Laffin, L Holzhauser, ... Journal of cardiac failure 26 (2), 128-135, 2020 | 39 | 2020 |
| Aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension: the target-HTN randomized clinical trial LJ Laffin, D Rodman, JM Luther, A Vaidya, MR Weir, N Rajicic, ... Jama 330 (12), 1140-1150, 2023 | 36 | 2023 |
| Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers LJ Laffin, D Bruemmer, M Garcia, DM Brennan, E McErlean, DS Jacoby, ... Journal of the American College of Cardiology 81 (1), 1-12, 2023 | 33 | 2023 |
| Cardiac rehabilitation is essential in the COVID-19 era: delivering uninterrupted heart care based on the Cleveland Clinic experience EH Van Iterson, LJ Laffin, M Crawford, D Mc Mahan, L Cho, U Khot Journal of cardiopulmonary rehabilitation and prevention 41 (2), 88-92, 2021 | 29 | 2021 |
| Artificial intelligence and hypertension: recent advances and future outlook T Chaikijurajai, LJ Laffin, WHW Tang American journal of hypertension 33 (11), 967-974, 2020 | 28 | 2020 |
| Hypertension and new treatment approaches targeting the sympathetic nervous system LJ Laffin, GL Bakris Current opinion in pharmacology 21, 20-24, 2015 | 28 | 2015 |
Erik H. Van Iterson, PhD, MS, MACleveland ClinicVerified email at ccf.org
